FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767553670> ?p ?o ?g. }

• W2767553670 endingPage "e184" @default.
• W2767553670 startingPage "e177" @default.
• W2767553670 abstract "The current study aimed to comprehensively investigate the impact of various clinicopathologic features on the efficacy of programmed cell death-1 (PD-1) and ligand (PD-L1) inhibitors in patients with previously treated non-small-cell lung cancer (NSCLC).Randomized controlled trials that compared PD-1/PD-L1-inhibitor monotherapy with chemotherapy or placebo in patients with previously treated NSCLC were included.Five trials were included (n = 3025). For all studies, PD-1/PD-L1 inhibitors significantly prolonged overall survival (OS) (hazard ratio [HR], 0.70; P < .001) and progression-free survival (PFS) versus chemotherapy (HR, 0.86; P = .020). Subgroup analysis showed that anti-PD-1/PD-L1 monotherapy could markedly improve OS in elderly patients (HR, 0.69; P < .001), female patients (HR, 0.70; P < .001), never-smoking patients (HR, 0.73; P = .001), and patients with a histology of squamous cell carcinoma (HR, 0.67; P < .001), but not PFS in the elderly and female patient groups. Notably, PD-1/PD-L1 inhibitors cannot prolong both OS (HR, 0.76; P = .390) and PFS (HR, 0.74; P = .210) in patients with central nervous system (CNS) metastasis, whereas patients without CNS metastasis could benefit from anti-PD-1/PD-L1 monotherapy on OS (HR, 0.71; P < .001).PD-1/PD-L1-inhibitor monotherapy could significantly prolong both OS and PFS in patients with previously treated NSCLC. Subgroup analyses showed that most patients including elderly, females, never-smokers, and patients with squamous cell carcinomas do benefit. However, whether patients with CNS metastasis could benefit from anti-PD-1/PD-L1 monotherapy requires further validation." @default.
• W2767553670 created "2017-11-17" @default.
• W2767553670 creator A5006613618 @default.
• W2767553670 creator A5016049048 @default.
• W2767553670 creator A5021941803 @default.
• W2767553670 creator A5023366097 @default.
• W2767553670 creator A5029411467 @default.
• W2767553670 creator A5030449789 @default.
• W2767553670 creator A5080382748 @default.
• W2767553670 creator A5087945394 @default.
• W2767553670 date "2018-03-01" @default.
• W2767553670 modified "2023-10-15" @default.
• W2767553670 title "Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non–small-cell Lung Cancer" @default.
• W2767553670 cites W1584365424 @default.
• W2767553670 cites W1982488143 @default.
• W2767553670 cites W2012932483 @default.
• W2767553670 cites W2033577259 @default.
• W2767553670 cites W2049553585 @default.
• W2767553670 cites W2088095316 @default.
• W2767553670 cites W2101653483 @default.
• W2767553670 cites W2104347254 @default.
• W2767553670 cites W2111346510 @default.
• W2767553670 cites W2120562400 @default.
• W2767553670 cites W2131876608 @default.
• W2767553670 cites W2156353875 @default.
• W2767553670 cites W2160834915 @default.
• W2767553670 cites W2198093519 @default.
• W2767553670 cites W2207587871 @default.
• W2767553670 cites W2272984102 @default.
• W2767553670 cites W2288908606 @default.
• W2767553670 cites W2293531514 @default.
• W2767553670 cites W2293828571 @default.
• W2767553670 cites W2295152675 @default.
• W2767553670 cites W2312518973 @default.
• W2767553670 cites W2397460919 @default.
• W2767553670 cites W2416791964 @default.
• W2767553670 cites W2435563082 @default.
• W2767553670 cites W2441578200 @default.
• W2767553670 cites W2493219106 @default.
• W2767553670 cites W2509195076 @default.
• W2767553670 cites W2527905628 @default.
• W2767553670 cites W2547310148 @default.
• W2767553670 cites W2559382297 @default.
• W2767553670 cites W2567564314 @default.
• W2767553670 cites W2578528809 @default.
• W2767553670 cites W2589298520 @default.
• W2767553670 doi "https://doi.org/10.1016/j.cllc.2017.10.018" @default.
• W2767553670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29175386" @default.
• W2767553670 hasPublicationYear "2018" @default.
• W2767553670 type Work @default.
• W2767553670 sameAs 2767553670 @default.
• W2767553670 citedByCount "6" @default.
• W2767553670 countsByYear W27675536702018 @default.
• W2767553670 countsByYear W27675536702019 @default.
• W2767553670 countsByYear W27675536702022 @default.
• W2767553670 crossrefType "journal-article" @default.
• W2767553670 hasAuthorship W2767553670A5006613618 @default.
• W2767553670 hasAuthorship W2767553670A5016049048 @default.
• W2767553670 hasAuthorship W2767553670A5021941803 @default.
• W2767553670 hasAuthorship W2767553670A5023366097 @default.
• W2767553670 hasAuthorship W2767553670A5029411467 @default.
• W2767553670 hasAuthorship W2767553670A5030449789 @default.
• W2767553670 hasAuthorship W2767553670A5080382748 @default.
• W2767553670 hasAuthorship W2767553670A5087945394 @default.
• W2767553670 hasConcept C121608353 @default.
• W2767553670 hasConcept C126322002 @default.
• W2767553670 hasConcept C142724271 @default.
• W2767553670 hasConcept C143998085 @default.
• W2767553670 hasConcept C204787440 @default.
• W2767553670 hasConcept C207103383 @default.
• W2767553670 hasConcept C27081682 @default.
• W2767553670 hasConcept C2776256026 @default.
• W2767553670 hasConcept C2776694085 @default.
• W2767553670 hasConcept C2777701055 @default.
• W2767553670 hasConcept C2778164965 @default.
• W2767553670 hasConcept C2779013556 @default.
• W2767553670 hasConcept C2781053074 @default.
• W2767553670 hasConcept C44249647 @default.
• W2767553670 hasConcept C71924100 @default.
• W2767553670 hasConcept C90924648 @default.
• W2767553670 hasConceptScore W2767553670C121608353 @default.
• W2767553670 hasConceptScore W2767553670C126322002 @default.
• W2767553670 hasConceptScore W2767553670C142724271 @default.
• W2767553670 hasConceptScore W2767553670C143998085 @default.
• W2767553670 hasConceptScore W2767553670C204787440 @default.
• W2767553670 hasConceptScore W2767553670C207103383 @default.
• W2767553670 hasConceptScore W2767553670C27081682 @default.
• W2767553670 hasConceptScore W2767553670C2776256026 @default.
• W2767553670 hasConceptScore W2767553670C2776694085 @default.
• W2767553670 hasConceptScore W2767553670C2777701055 @default.
• W2767553670 hasConceptScore W2767553670C2778164965 @default.
• W2767553670 hasConceptScore W2767553670C2779013556 @default.
• W2767553670 hasConceptScore W2767553670C2781053074 @default.
• W2767553670 hasConceptScore W2767553670C44249647 @default.
• W2767553670 hasConceptScore W2767553670C71924100 @default.
• W2767553670 hasConceptScore W2767553670C90924648 @default.
• W2767553670 hasIssue "2" @default.
• W2767553670 hasLocation W27675536701 @default.

• next